BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 20170717)

  • 1. Preparation, Characterization, and in vivo Evaluation of NK4-Conjugated Hydroxycamptothecin-Loaded Liposomes.
    Zhou T; Zhang W; Cheng D; Tang X; Feng J; Wu W
    Int J Nanomedicine; 2020; 15():2277-2286. PubMed ID: 32280220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Layer-by-layer nanoencapsulation of camptothecin with improved activity.
    Parekh G; Pattekari P; Joshi C; Shutava T; DeCoster M; Levchenko T; Torchilin V; Lvov Y
    Int J Pharm; 2014 Apr; 465(1-2):218-27. PubMed ID: 24508806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulating 10-hydroxycamptothecin into nanoemulsion with functional excipient tributyrin: An innovative strategy for targeted hepatic cancer chemotherapy.
    Yang S; Lin HS; Zhang L; Chi-Lui Ho P
    Int J Pharm; 2024 Apr; 654():123945. PubMed ID: 38403088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalized hydrophobic poly(glycerol-co-ε-caprolactone) depots for controlled drug release.
    Wolinsky JB; Yohe ST; Colson YL; Grinstaff MW
    Biomacromolecules; 2012 Feb; 13(2):406-11. PubMed ID: 22242897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 10-hydroxycamptothecin-loaded starch-based microcapsules with the stepwise responsive release strategy for targeted controlled release.
    Meng Q; Zhong S; Wang J; Gao Y; Cui X
    Int J Biol Macromol; 2023 Dec; 252():126424. PubMed ID: 37607650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of an anti-tumor drug into nanocrystalline assemblies for sustained drug release.
    Yang X; Wu S; Li Y; Huang Y; Lin J; Chang D; Ye S; Xie L; Jiang Y; Hou Z
    Chem Sci; 2015 Mar; 6(3):1650-1654. PubMed ID: 28694944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrospun Drug-Loaded and Gene-Loaded Nanofibres: The Holy Grail of Glioblastoma Therapy?
    Louis L; Chee BS; McAfee M; Nugent M
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrospun Nanofibers of Polycaprolactone/Collagen as a Sustained-Release Drug Delivery System for Artemisinin.
    Huo P; Han X; Zhang W; Zhang J; Kumar P; Liu B
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluronic F127-Modified Electrospun Fibrous Meshes for Synergistic Combination Chemotherapy of Colon Cancer.
    Xie D; Ma P; Ding X; Yang X; Duan L; Xiao B; Yi S
    Front Bioeng Biotechnol; 2020; 8():618516. PubMed ID: 33665187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrospun Nanofibers for Cancer Therapy.
    Luo H; Jie T; Zheng L; Huang C; Chen G; Cui W
    Adv Exp Med Biol; 2021; 1295():163-190. PubMed ID: 33543460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aliphatic Polyester Nanofibers Functionalized with Cyclodextrins and Cyclodextrin-Guest Inclusion Complexes.
    Narayanan G; Shen J; Boy R; Gupta BS; Tonelli AE
    Polymers (Basel); 2018 Apr; 10(4):. PubMed ID: 30966463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrospinning of Cyclodextrin Functional Nanofibers for Drug Delivery Applications.
    Topuz F; Uyar T
    Pharmaceutics; 2018 Dec; 11(1):. PubMed ID: 30586876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional Electrospun Nanofibers for Enhancing Localized Cancer Treatment.
    Fu Y; Li X; Ren Z; Mao C; Han G
    Small; 2018 Jun; ():e1801183. PubMed ID: 29952070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current strategies for sustaining drug release from electrospun nanofibers.
    Chou SF; Carson D; Woodrow KA
    J Control Release; 2015 Dec; 220(Pt B):584-91. PubMed ID: 26363300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in drug delivery via electrospun and electrosprayed nanomaterials.
    Zamani M; Prabhakaran MP; Ramakrishna S
    Int J Nanomedicine; 2013; 8():2997-3017. PubMed ID: 23976851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release modulation and cytotoxicity of hydroxycamptothecin-loaded electrospun fibers with 2-hydroxypropyl-beta-cyclodextrin inoculations.
    Xie C; Li X; Luo X; Yang Y; Cui W; Zou J; Zhou S
    Int J Pharm; 2010 May; 391(1-2):55-64. PubMed ID: 20170717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activities of emulsion electrospun fibers with core loading of hydroxycamptothecin via intratumoral implantation.
    Luo X; Xie C; Wang H; Liu C; Yan S; Li X
    Int J Pharm; 2012 Apr; 425(1-2):19-28. PubMed ID: 22265915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimetastasis and antitumor efficacy promoted by sequential release of vascular disrupting and chemotherapeutic agents from electrospun fibers.
    Luo X; Zhang H; Chen M; Wei J; Zhang Y; Li X
    Int J Pharm; 2014 Nov; 475(1-2):438-49. PubMed ID: 25218185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoted antitumor activities of acid-labile electrospun fibers loaded with hydroxycamptothecin via intratumoral implantation.
    Luo X; Xu G; Song H; Yang S; Yan S; Jia G; Li X
    Eur J Pharm Biopharm; 2012 Nov; 82(3):545-53. PubMed ID: 22995703
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.